工研院開放實驗室生物科技新創公司之研究

Abstract

生物科技為最具遠景的新興科技之一，其特點為研發時間長、資金需求龐大、以及產品受到的法規限制嚴格。台灣生技產業應朝何方向發展及台灣生技新創公司應如何爭取開創資金來源及保持公司營運是本研究所關心的議題。 本研究針對工研院開放實驗室中6個生技新創公司進行訪談，進行個案研究。透過文獻探討，對全球生技產業進行產業分析。業界專家一般認為國內生技產業應朝向利基市場發展，如：生物晶片、學名藥、或孤兒藥市場；研究成果發現成立時間三年以下的生技業者強調技術為生技新創公司經營之重點；成立三年以上的生技業者則強調資金及行銷為成敗關鍵。本研究結果也指出創業者組織技術團隊及募集資金的能力是影響公司持續發展的關鍵。

Biotechnology is one of the most promising emerging technologies. The characters of biotechnology are long time in R&D, huge amount of capital, and lots of law restrictions. How a Taiwan bio-tech start-up company get sufficient amount of capital and keep the operation of a startup company in Taiwan that has no sufficient amount of capital is what we concern about. The purpose of this study was to explore the key factors that influence Taiwanese bio-tech start-up companies’ chances of success. In this study, six bio-tech start-up companies that were being incubated by the Open Labs of Industrial Technologies Research Institute (ITRI) in Taiwan have been interviewed. Combined with industrial analysis and case study, the study found out biotechnology industry in Taiwan should focus in nich market like bio-chips, generic drugs, and orphan drugs. Those bio-tech start-up companies less than three years in existence emphasized technology as the key success factor. While bio-tech companies more than three years in existence emphasized capital and marketing as the two key success factors. The study also concluded that the entrepreneur really plays a key role in gathering a strong technical team and successfully soliciting capital investment from investors.